Nektar Therapeutics
NKTR
#4943
Rang
€1.75 Md
Capitalisation boursière
51,32 €
Prix de l'action
-3.63%
Changement (1 jour)
2.18%
Changement (1 an)

Nektar Therapeutics (NKTR) - Dette totale

Dette totale au bilan au Juin 2026 : 69.25 Millions d'euros

Selon les derniers rapports financiers de Nektar Therapeutics , la dette totale de l'entreprise est de 69.25 Millions d'euros. La dette totale d'une entreprise est la somme de toutes les dettes courantes et non courantes.

Nektar Therapeutics - Dette totale au bilan (de 1996 à 2026)

Dette totale par année

Année Dette totale Changement
2025-12-31€72.99 M-25.94%
2024-12-31€98.56 M-7.49%
2023-12-31€0.10 Md-13.09%
2022-12-31€0.12 Md-3.04%
2021-12-31€0.12 Md3.47%
2020-12-31€0.12 Md-66.46%
2019-12-31€0.36 Md68.78%
2018-12-31€0.21 Md5.63%
2017-12-31€0.20 Md-11.71%
2016-12-31€0.23 Md2.24%
2015-12-31€0.22 Md106.01%
2014-12-31€0.10 Md11.11%
2013-12-31€98.9 M-4.23%
2012-12-31€0.10 Md-41.57%
2011-12-31€0.17 Md1.35%
2010-12-31€0.17 Md6.89%
2009-12-31€0.16 Md-3.06%
2008-12-31€0.16 Md-27%
2007-12-31€0.23 Md-30.56%
2006-12-31€0.33 Md-10.28%
2005-12-31€0.37 Md152.2%
2004-12-31€0.14 Md-53.02%
2003-12-31€0.31 Md-1.64%
2002-12-31€0.31 Md-15.48%
2001-12-31€0.37 Md10.53%
2000-12-31€0.33 Md201.72%
1999-12-31€0.11 Md2572.22%
1998-12-31€4.21 M-3.49%
1997-12-31€4.36 M1196.25%
1996-12-31€0.33 M

Dette totale pour des entreprises similaires ou concurrentes

Entreprise Dette totale/th> Dette totale différencediff. Pays
Johnson & Johnson
JNJ
€43.23 Md 62,321.71%🇺🇸 USA
Pfizer
PFE
€55.71 Md 80,344.52%🇺🇸 USA
Amgen
AMGN
€50.51 Md 72,846.69%🇺🇸 USA
Baxter
BAX
€8.52 Md 12,205.87%🇺🇸 USA
Merck
MRK
€47.52 Md 68,521.11%🇺🇸 USA
AstraZeneca
AZN
€28.42 Md 40,939.51%🇬🇧 UK
Richardson Electronics
RELL
€1.22 M-98.23%🇺🇸 USA
Alkermes
ALKS
€1.39 Md 1,913.42%🇮🇪 Ireland